{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T11:51:11Z","timestamp":1795002671488,"version":"4.9.1"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.psyneuen.2026.108026","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:09:57Z","timestamp":1791162597000},"page":"108026","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Should genetic polymorphism information be incorporated into future salivary cortisol studies: Insights from biological psychiatry"],"prefix":"10.1016","volume":"195","author":[{"given":"Jerrold S.","family":"Meyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2026.108026_bib1","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1096\/fj.07-8140com","article-title":"Identification of polymorphisms in the human 11beta-hydroxysteroid dehydrogenase type 2 gene promoter: functional characterization and relevance for salt sensitivity","volume":"21","author":"Alikhani-Koupaei","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.psyneuen.2026.108026_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2026.1773677","article-title":"Pharmacogenetics of antidepressant response: a focused review on CYP2C19, CYP2D6, SLC6A4, and HTR2A polymorphisms","volume":"17","author":"Blambila","year":"2026","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.psyneuen.2026.108026_bib3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/cpt.2903","article-title":"Clinical pharmacogenetics implementation consortium (CPIC) guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A genotypes and serotonin reuptake inhibitor antidepressants","volume":"114","author":"Bousman","year":"2023","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.psyneuen.2026.108026_bib4","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s10038-020-00895-6","article-title":"Variation in the SERPINA6\/SERPINA1 locus alters morning plasma cortisol, hepatic corticosteroid binding globulin expression, gene expression in peripheral tissues, and risk of cardiovascular disease","volume":"66","author":"Crawford","year":"2021","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.psyneuen.2026.108026_bib5","series-title":"Psychoneuroendocrinology","article-title":"Accounting for genetic heterogeneity in salivary cortisol studies: A path forward for Psychoneuroendocrinology?","author":"Granger","year":"2026"},{"key":"10.1016\/j.psyneuen.2026.108026_bib6","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1016\/j.jchromb.2009.09.014","article-title":"Simultaneous measurement of cortisol and cortisone in human saliva using liquid chromatography-tandem mass spectrometry: application in basal and stimulated conditions","volume":"877","author":"Perogamvros","year":"2009","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.psyneuen.2026.108026_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psyneuen.2018.04.009","article-title":"Polygenic risk score of SERPINA6\/SERPINA1 associates with diurnal and stress-induced HPA axis activity in children","volume":"93","author":"Utge","year":"2018","journal-title":"Psychoneuroendocrinology"}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453026002866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453026002866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T22:04:31Z","timestamp":1794953071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453026002866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":7,"alternative-id":["S0306453026002866"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2026.108026","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Should genetic polymorphism information be incorporated into future salivary cortisol studies: Insights from biological psychiatry","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2026.108026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108026"}}